Literature DB >> 28468989

Citron kinase - renaissance of a neglected mitotic kinase.

Pier Paolo D'Avino1.   

Abstract

Cell division controls the faithful segregation of genomic and cytoplasmic materials between the two nascent daughter cells. Members of the Aurora, Polo and cyclin-dependent (Cdk) kinase families are known to regulate multiple events throughout cell division, whereas another kinase, citron kinase (CIT-K), for a long time has been considered to function solely during cytokinesis, the last phase of cell division. CIT-K was originally proposed to regulate the ingression of the cleavage furrow that forms at the equatorial cortex of the dividing cell after chromosome segregation. However, studies in the last decade have clarified that this kinase is, instead, required for the organization of the midbody in late cytokinesis, and also revealed novel functions of CIT-K earlier in mitosis and in DNA damage control. Moreover, CIT-K mutations have recently been linked to the development of human microcephaly, and CIT-K has been identified as a potential target in cancer therapy. In this Commentary, I describe and re-evaluate the functions and regulation of CIT-K during cell division and its involvement in human disease. Finally, I offer my perspectives on the open questions and future challenges that are necessary to address, in order to fully understand this important and yet unjustly neglected mitotic kinase.
© 2017. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  Cancer; Cell division; Citron kinase; Microcephaly; Polyploidy; Spindle orientation

Mesh:

Substances:

Year:  2017        PMID: 28468989     DOI: 10.1242/jcs.200253

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  11 in total

1.  Citron Rho-interacting kinase silencing causes cytokinesis failure and reduces tumor growth in multiple myeloma.

Authors:  Ilyas Sahin; Yawara Kawano; Romanos Sklavenitis-Pistofidis; Michele Moschetta; Yuji Mishima; Salomon Manier; Antonio Sacco; Ruben Carrasco; Rafael Fonseca; Aldo M Roccaro; Thomas Witzig; Irene M Ghobrial
Journal:  Blood Adv       Date:  2019-04-09

Review 2.  Fine-tuning cell organelle dynamics during mitosis by small GTPases.

Authors:  Zijian Zhang; Wei Zhang; Quentin Liu
Journal:  Front Med       Date:  2022-06-27       Impact factor: 9.927

3.  High Expression of Citron Kinase Contributes to the Development of Esophageal Squamous Cell Carcinoma.

Authors:  Wenfeng Lu; Yun Dong; Qing Cui; Yuhan Wang; Xiwen Yang; Xiaoyue Cai; Ming Zhang
Journal:  Front Genet       Date:  2021-07-07       Impact factor: 4.599

4.  Rho-dependent control of the Citron kinase, Sticky, drives midbody ring maturation.

Authors:  Nour El-Amine; Sabrya C Carim; Denise Wernike; Gilles R X Hickson
Journal:  Mol Biol Cell       Date:  2019-06-05       Impact factor: 4.138

Review 5.  Of rings and spines: The multiple facets of Citron proteins in neural development.

Authors:  Federico T Bianchi; Marta Gai; Gaia E Berto; Ferdinando Di Cunto
Journal:  Small GTPases       Date:  2017-11-29

Review 6.  The postmitotic midbody: Regulating polarity, stemness, and proliferation.

Authors:  Eric Peterman; Rytis Prekeris
Journal:  J Cell Biol       Date:  2019-11-05       Impact factor: 10.539

Review 7.  The Mitotic Apparatus and Kinetochores in Microcephaly and Neurodevelopmental Diseases.

Authors:  Francesca Degrassi; Michela Damizia; Patrizia Lavia
Journal:  Cells       Date:  2019-12-24       Impact factor: 6.600

8.  Citron kinase interacts with LATS2 and inhibits its activity by occluding its hydrophobic phosphorylation motif.

Authors:  Thi Hai Yen Tran; Dae-Wook Yang; Minchul Kim; Da-Hye Lee; Marta Gai; Ferdinando Di Cunto; Kwang-Wook Choi; Dae-Sik Lim
Journal:  J Mol Cell Biol       Date:  2019-12-23       Impact factor: 6.216

9.  Gene expression of cytokinesis regulators PRC1, KIF14 and CIT has no prognostic role in colorectal and pancreatic cancer.

Authors:  Vojtech Hanicinec; Veronika Brynychova; Jachym Rosendorf; Richard Palek; Vaclav Liska; Martin Oliverius; Zdenek Kala; Beatrice Mohelnikova-Duchonova; Ivona Krus; Pavel Soucek
Journal:  Oncol Lett       Date:  2021-06-09       Impact factor: 2.967

Review 10.  Non-coding RNAs: Emerging Regulators of Sorafenib Resistance in Hepatocellular Carcinoma.

Authors:  Yongting Lai; Bing Feng; Mubalake Abudoureyimu; Yingru Zhi; Hao Zhou; Ting Wang; Xiaoyuan Chu; Ping Chen; Rui Wang
Journal:  Front Oncol       Date:  2019-11-05       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.